Q3 2022 Holdings
Filed 2022-11-14 | 49 holdings | $27.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $15.9M | 683,425 | 58.1% |
| Centene Corp del(CNC) | COM | 15135B101 | $9.9M | 127,011 | 36.1% |
| ANI Pharmaceuticals Inc(ANIP) | COM | 00182C103 | $1.3M | 40,000 | 4.7% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $38.2K | 282,399 | 0.1% |
| Apellis Pharmaceuticals Inc(APLS)Put | COM | 03753U106 | $34.7K | 507,700 | 0.1% |
| GSK PLC(GSK) | SPONSORED ADS | 37733W204 | $23.3K | 790,600 | 0.1% |
| Medicus Sciences Acquisition | CL A SHS | G5960S108 | $23.0K | 2,323,000 | 0.1% |
| Relmada Therapeutics Inc(RLMD)Put | COM | 75955J402 | $22.4K | 606,200 | 0.1% |
| Prometheus Biosciences IncPut | COM | 74349U108 | $19.6K | 332,200 | 0.1% |
| Organon & Co(OGN) | COMMON STOCK | 68622V106 | $14.7K | 628,836 | 0.1% |
| Cigna Corp(CI) | COM | 125523100 | $14.6K | 52,611 | 0.1% |
| Sanofi SA(SNY) | SPONSORED ADR | 80105N105 | $13.6K | 356,888 | 0.0% |
| Inogen Inc(INGN) | COM | 45780L104 | $12.7K | 521,295 | 0.0% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $9.4K | 44,959 | 0.0% |
| The Beauty Health Co(SKIN) | COM CL A | 88331L108 | $7.8K | 658,964 | 0.0% |
| Smith & Nephew PLC(SNN) | SPDN ADR NEW | 83175M205 | $5.3K | 228,390 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $4.8K | 488,965 | 0.0% |
| Point Biopharma Global Inc | COM | 730541109 | $4.2K | 544,545 | 0.0% |
| Inari Medical Inc(NARIUSD) | COM | 45332Y109 | $4.2K | 57,466 | 0.0% |
| Universal Health Services Inc(UHS) | CL B | 913903100 | $3.6K | 40,725 | 0.0% |
| Eucrates Biomedical Acquisition Corp. | UNIT 10/23/2027 | G3141W114 | $2.5K | 248,674 | 0.0% |
| Health Sciences Acquisitions Corp 2 | ORD SHS | G4411D109 | $2.5K | 250,000 | 0.0% |
| Aeglea BIO Therapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.5K | 4,668,536 | 0.0% |
| X4 Pharmaceuticals Inc(ASNSUSD) | COM | 98420X103 | $2.4K | 1,418,461 | 0.0% |
| Modular Medical Inc(MODD) | COM NEW | 60785L207 | $2.4K | 574,352 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.9K | 555,610 | 0.0% |
| Bausch Health Companies Inc(BHC)Put | COM | 071734107 | $1.9K | 281,200 | 0.0% |
| Renovacor Inc | COM | 75989E106 | $1.9K | 735,908 | 0.0% |
| Merus NV | COM | N5749R100 | $1.8K | 87,953 | 0.0% |
| Affimed NV | COM | N01045108 | $1.7K | 821,065 | 0.0% |
| Iveric BIO Inc(OPHTEUR)Put | COM | 46583P102 | $1.6K | 86,400 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $1.3K | 152,159 | 0.0% |
| Savara Inc(SVRA) | COM | 805111101 | $1.3K | 856,428 | 0.0% |
| Moleculin Biotech Inc | COM | 60855D200 | $1.1K | 1,036,853 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $1.0K | 70,000 | 0.0% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $784 | 260,448 | 0.0% |
| Connect Biopharma Holdings LTD | ADS | 207523101 | $771 | 597,678 | 0.0% |
| Aslan Pharmaceuticals LTD | ADS | 04522R101 | $761 | 1,270,758 | 0.0% |
| Elevation Oncology Inc | COM | 28623U101 | $406 | 359,731 | 0.0% |
| Nextcure Inc | COM | 65343E108 | $358 | 130,000 | 0.0% |
| Caremax Inc | COM CL A | 14171W103 | $218 | 30,741 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $141 | 102,049 | 0.0% |
| Neubase Therapeutics Inc | COM | 64132K102 | $102 | 259,441 | 0.0% |
| Nyxoah SA(NYXH) | SHS | B6S7WD106 | $101 | 16,110 | 0.0% |
| Clene Inc.(CLNNEUR)Put | COMMON STOCK | 185634102 | $64 | 22,700 | 0.0% |
| Humacyte Inc | *W EXP 09/21/202 | 44486Q111 | $58 | 49,998 | 0.0% |
| Renovacor Inc | *W EXP 99/99/999 | 75989E114 | $37 | 400,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $25 | 38,312 | 0.0% |
| Caremax Inc | *W EXP 06/08/202 | 14171W111 | $23 | 12,808 | 0.0% |